Jinkyoung Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Development and Validation of a Next-Generation Sequencing-Based Multigene Assay to Predict the Prognosis of Estrogen Receptor-Positive, HER2-Negative Breast Cancer.

Development and Validation of a Next-Generation Sequencing-Based Multigene Assay to Predict the Prognosis of Estrogen Receptor-Positive, HER2-Negative Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 30, 2020

Examination of the Biomark assay as an alternative to Oncotype DX for defining chemotherapy benefit.

Examination of the Biomark assay as an alternative to Oncotype DX for defining chemotherapy benefit.

Journal: Oncology letters
Published: July 09, 2018

Optimization of RNA Extraction from Formalin-Fixed Paraffin-Embedded Blocks for Targeted Next-Generation Sequencing.

Optimization of RNA Extraction from Formalin-Fixed Paraffin-Embedded Blocks for Targeted Next-Generation Sequencing.

Journal: Journal of breast cancer
Published: August 28, 2017

EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.

EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.

Journal: Oncotarget
Published: July 05, 2016

Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.

Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.

Journal: Oncology reports
Published: December 14, 2015

Hornerin Is Involved in Breast Cancer Progression.

Hornerin Is Involved in Breast Cancer Progression.

Journal: Journal of breast cancer
Published: September 23, 2015

Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.

Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 24, 2015

Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.

Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.

Journal: Oncology reports
Published: March 24, 2014

HRG-β1-driven ErbB3 signaling induces epithelial-mesenchymal transition in breast cancer cells.

HRG-β1-driven ErbB3 signaling induces epithelial-mesenchymal transition in breast cancer cells.

Journal: BMC cancer
Published: April 02, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026